Formerly SpinOut Advisory
You have to live the founder journey to really understand it.
The pressure, uncertainty and responsibility of building an early-stage business are difficult to appreciate from the outside. I’ve lived that journey myself — which is why my support starts with understanding the founder, not simply analysing the business.
Early-stage founders are expected to make difficult commercial, financial, people and funding decisions remarkably quickly — often while still developing the product or technology that started the venture.
Being a founder can feel like a solitary journey. It doesn't have to be.
I work alongside founders as an experienced, independent sounding board: helping them work through difficult decisions, maintain focus, identify risks early and keep priorities moving.
This is not occasional mentoring or another startup programme. It is continuing, practical support from someone who has spent ten years building, funding and leading an early-stage venture.
Perspective
Decisions
Governance
Momentum
The Start-up versus Survival Gap
Companies & Intellectual Property Commision
South Africa is not short of company registrations. In 2024/25, CIPC processed 488,355 company registrations, up from roughly 402,500 in 2023/24. Over the last five financial years, annual company registrations have sat in the 400,000–510,000 range.
South Africa does not have a start-up creation problem. It has a start-up survival, discipline and scale-readiness problem.
Global Entrepreneurship Report.
The GEM 2025/2026 Global Report found that 64.4% of South African adults see good opportunities to start a business and early-stage entrepreneurial activity has risen to almost 15%. Yet only 3.9% of adults own an established business. South Africa's entrepreneurial environment also remains weak, ranking 47th out of 53 GEM economies.
The problem is usually not that the science is weak. It is that the company is not governable, fundable or execution-ready by the time the next investor starts due diligence. South African academic spin-offs often face both a funding gap and an operational gap: limited business skills, commercial experience and market-building capability after the technology leaves the university environment
What Founders have said
Gokul Nair: Co-founder, Impulse Biomedical:
“Working with Belinda was invaluable for us as an early-stage medtech company. She helped us navigate a grant process in a way that significantly reduced mistakes and ensured a much smoother flow of funds into the business.
Belinda is sharp, thoughtful and detail-oriented, but she also understands the bigger picture founders are trying to build towards. I would highly recommend her to any start-up looking to become investor-ready and approach funding with confidence.”
I've sat on the founder's side of the table
Ten years building and leading an early-stage biotechnology venture taught me what frameworks and textbooks cannot: its an emotional roller coaster, with with daily challenges you have to tackle on your own - cash runway shortens, market shifts, team culture takes strain, moving regulatory goalposts, technical progress is delayed and your Board and investors need answers. To name a few.
